Last checked at 14 Sep 2010 14:09
|
| ||||
| TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | ||||
|
|
| |||
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | Surgical Innovations Group | |||
| 2 Reason for the notification (please tick the appropriate box or boxes): | ||||
| An acquisition or disposal of voting rights |
| |||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
| |||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
| |||
| An event changing the breakdown of voting rights |
| |||
| Other (please specify): | Amendment | √ | ||
| 3. Full name of person(s) subject to the notification obligation: iii | Barclays PLC | |||
| 4. Full name of shareholder(s) (if different from 3.):iv |
| |||
| 5. Date of the transaction and date on which the threshold is crossed or reached: v | N/A | |||
| 6. Date on which issuer notified: | 8 September 2010 | |||
| 7. Threshold(s) that is/are crossed or reached: vi, vii | N/A | |||
| 8. Notified details: | ||||||||||||||||
| A: Voting rights attached to shares viii, ix | ||||||||||||||||
| Class/type of shares if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | ||||||||||||||
| Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights x | ||||||||||||
| Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
|
| N/A | N/A |
|
| Below notifiable threshold |
| Below notifiable threshold | |||||||||
| GB0004016704 | ||||||||||||||||
|
| ||||||||||||||||
| B: Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument | Expiration date xiii | Exercise/ Conversion Period xiv | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights | ||||||||||||
|
|
|
|
|
| ||||||||||||
|
| ||||||||||||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument | Exercise price | Expiration date xvii | Exercise/ Conversion period xviii | Number of voting rights instrument refers to
| % of voting rights xix, xx
| |||||||||||
|
|
|
|
|
| Nominal | Delta | ||||||||||
|
|
| |||||||||||||||
|
| ||||||||||||||||
| Total (A+B+C) | ||||||||||||||||
| Number of voting rights | Percentage of voting rights | |||||||||||||||
| Below notifiable threshold | Below notifiable threshold | |||||||||||||||
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi | ||
|
| ||
|
| ||
| Proxy Voting: | ||
| 10. Name of the proxy holder: |
| |
| 11. Number of voting rights proxy holder will cease to hold: |
| |
| 12. Date on which proxy holder will cease to hold voting rights: |
| |
|
| ||
| 13. Additional information: | Please be advised that the interest disclosed in Barclays previous Notification of Major Interests in Shares was subject to an exemption within the Disclosure and Transparency Rules and therefore did not require notification. Consequently, Barclays plc does not have a reportable interest in this issuer. | |
| 14. Contact name: | Geoff Smith | |
| 15. Contact telephone number: | 020 7116 2913 | |
Enquiries:
|
|
|
| Surgical Innovations Group plc | 0113 230 7597 |
| Graham Bowland |
|
|
|
|
| Westhouse Securities Limited | 0113 246 2610 |
| Tim Feather / Matthew Johnson |
|